EJNMMI Research

Scope & Guideline

Advancing the Frontiers of Nuclear Medicine and Imaging.

Introduction

Welcome to the EJNMMI Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of EJNMMI Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2191-219x
PublisherSPRINGER
Support Open AccessYes
CountryGermany
TypeJournal
Convergefrom 2011 to 2024
AbbreviationEJNMMI RES / EJNMMI Res.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

EJNMMI Research is a leading journal that focuses on the advancements and applications of nuclear medicine and molecular imaging. The journal aims to publish high-quality research that enhances the understanding and development of novel imaging techniques and radiopharmaceuticals, contributing to improved diagnostics and therapeutics in various medical fields.
  1. Molecular Imaging Techniques:
    The journal emphasizes innovative imaging modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), and hybrid imaging techniques, which are crucial for diagnosing and monitoring diseases.
  2. Radiopharmaceutical Development:
    A significant focus is on the development and validation of new radiopharmaceuticals for both diagnostic and therapeutic applications, with an aim to improve imaging accuracy and patient outcomes.
  3. Clinical Applications and Trials:
    EJNMMI Research publishes studies that explore the clinical applications of imaging technologies, including their role in oncology, neurology, cardiology, and other fields, as well as the results from clinical trials.
  4. Quantitative Imaging and Dosimetry:
    The journal covers advances in quantitative imaging methodologies and dosimetry, which are essential for optimizing treatment plans in personalized medicine.
  5. Theranostics:
    The integration of diagnostics and therapeutics, or theranostics, is a key area of research, focusing on the use of imaging to guide targeted therapies.
  6. Artificial Intelligence and Imaging:
    There is a growing interest in the application of artificial intelligence and machine learning techniques to enhance imaging analysis and interpretation, which is a significant trend within the journal.
EJNMMI Research has been at the forefront of several emerging themes that reflect the latest advancements in nuclear medicine and molecular imaging. These trends are critical for researchers seeking to understand the future directions of this field.
  1. Artificial Intelligence in Imaging:
    The application of AI and machine learning for image reconstruction, analysis, and interpretation is rapidly gaining traction, as these technologies enhance diagnostic accuracy and efficiency.
  2. Radiomics and Imaging Biomarkers:
    The exploration of radiomics, which involves extracting a large number of features from medical images, is trending as a method for improving diagnosis and predicting treatment outcomes.
  3. Personalized Medicine:
    There is an increasing emphasis on personalized approaches in nuclear medicine, particularly in the context of cancer therapies that are tailored based on individual patient imaging and genetic profiles.
  4. Theranostic Approaches:
    The integration of diagnostic and therapeutic strategies, particularly using radioligands for targeted therapy, is emerging as a significant theme, reflecting the trend toward personalized treatment plans.
  5. Hybrid Imaging Technologies:
    The continued development and application of hybrid imaging technologies, such as PET/MRI and PET/CT, are trending, allowing for comprehensive assessments of complex diseases.
  6. Immuno-PET Techniques:
    The use of immuno-PET for evaluating immune responses and targeting specific biomarkers is gaining popularity, reflecting a broader interest in immunotherapy and its monitoring.

Declining or Waning

While EJNMMI Research continues to thrive in many areas, certain themes have become less prominent in recent publications. This decline may reflect shifts in research focus or advancements rendering previous methodologies less relevant.
  1. Traditional Imaging Techniques:
    There has been a noticeable decrease in publications focused exclusively on traditional imaging methods without the integration of newer technologies or advanced imaging analysis techniques.
  2. Invasive Imaging Procedures:
    Research papers emphasizing invasive imaging procedures are becoming less common as non-invasive techniques gain favor for their lower risk and improved patient comfort.
  3. Basic Science Studies:
    There has been a waning interest in purely basic science studies that do not translate directly to clinical applications, as the journal increasingly prioritizes translational research.
  4. Non-targeted Imaging Agents:
    The focus on non-specific or non-targeted imaging agents is decreasing, with a shift towards more personalized and targeted approaches in imaging.

Similar Journals

SEMINARS IN NUCLEAR MEDICINE

Transforming nuclear medicine through high-quality discourse.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0001-2998Frequency: 6 issues/year

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

Egyptian Journal of Radiology and Nuclear Medicine

Advancing the Frontiers of Radiology and Nuclear Medicine
Publisher: SPRINGERISSN: Frequency: 1 issue/year

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.

Journal of Clinical Imaging Science

Advancing the Frontiers of Clinical Imaging Research
Publisher: SCIENTIFIC SCHOLAR LLCISSN: 2156-7514Frequency: 4 issues/year

Welcome to the Journal of Clinical Imaging Science, a dedicated platform for disseminating pioneering research in the field of radiology, nuclear medicine, and imaging. Published by SCIENTIFIC SCHOLAR LLC, this peer-reviewed journal offers a prominent forum for researchers, professionals, and students to share insights and advancements that push the boundaries of clinical imaging practice and technology. With a proud history of publication since 2011 and converged years extending through 2024, the journal currently ranks in the top quartile (Q3) as per the 2023 categorization in the relevant field, positioning itself as a valuable resource among its peers. While embracing a non-open access model, it guarantees high-quality content that contributes to the 36th percentile of Scopus rankings for medicine and imaging sciences. The Journal of Clinical Imaging Science aspires to enhance the knowledge base in clinical settings and promote innovative methodologies, serving as an essential tool for advancing education and practice in imaging sciences.

CLINICAL NUCLEAR MEDICINE

Empowering Innovations in Clinical Practices
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0363-9762Frequency: 12 issues/year

CLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.

EJNMMI Physics

Elevating Knowledge in Medical Physics and Imaging Technologies.
Publisher: SPRINGERISSN: 2197-7364Frequency: 1 issue/year

EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

Hellenic Journal of Nuclear Medicine

Empowering Research and Innovation in Nuclear Medicine
Publisher: HELLENIC SOC NUCLEAR MEDICINEISSN: 1108-1430Frequency: 3 issues/year

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Transforming Diagnostics Through Cutting-Edge Research
Publisher: SPRINGERISSN: 1619-7070Frequency: 12 issues/year

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.

Molecular Imaging and Radionuclide Therapy

Connecting scholars to the forefront of radionuclide therapy.
Publisher: GALENOS PUBL HOUSEISSN: 2146-1414Frequency: 3 issues/year

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

SEMINARS IN ULTRASOUND CT AND MRI

Connecting Clinicians with Cutting-edge Imaging Research
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-2171Frequency: 6 issues/year

SEMINARS IN ULTRASOUND CT AND MRI is a prestigious academic journal dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Published by W B SAUNDERS CO-ELSEVIER INC, this journal has been a cornerstone of scholarly communication since 1984, providing a platform for high-quality research and review articles that enhance the understanding of diagnostic imaging techniques. With a current impact factor reflected in its Q3 quartile ranking among 333 journals in its category, it remains a valuable resource for researchers and clinicians alike. The journal's focus includes but is not limited to innovations in ultrasound, computed tomography, and magnetic resonance imaging, making it essential for professionals looking to stay at the forefront of imaging science. While it operates under a subscription model, its extensive archive of influential articles ensures ongoing access to critical knowledge and developments in the field. With a commitment to quality and relevance, SEMINARS IN ULTRASOUND CT AND MRI continues to contribute significantly to the evolving landscape of medical imaging.

Revista Espanola de Medicina Nuclear e Imagen Molecular

Pioneering Insights in Radiology and Molecular Imaging
Publisher: ELSEVIER ESPANA SLUISSN: 2253-654XFrequency: 6 issues/year

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.